Generics - Asia-Pacific, Politics

Filter

Current filters:

Asia-PacificPolitics

Popular Filters

Despite focus on generics, South Korean pharma market to reach $24.3 billion by 2020

Despite focus on generics, South Korean pharma market to reach $24.3 billion by 2020

10-04-2014

As a result of a high level of access to health care insurance and reimbursement, coupled with increasing…

Asia-PacificGenericsMarkets & MarketingPolitics

GMiA calls on Australian government to think before irreversible damage occurs to the generic medicines industry

GMiA calls on Australian government to think before irreversible damage occurs to the generic medicines industry

13-03-2014

At the Annual Professional Pharmacy (APP) conference in Australia today, Mark Crotty, chairman of the…

Asia-PacificAustraliaGenericsHealthcarePolitics

Mixed views on Grattan Institute report on drug price cuts impact in Australia

Mixed views on Grattan Institute report on drug price cuts impact in Australia

03-12-2013

The Grattan Institute has published an updated report on Australia's drug pricing, which has been applauded…

Asia-PacificAustraliaGenericsPoliticsPricing

No changes in Australian domestic IP warranted, say generic drugmakers

No changes in Australian domestic IP warranted, say generic drugmakers

26-11-2013

Members of the generic drugs industry are calling on the Australian government to support efforts to…

Asia-PacificGenericsNorth AmericaPatentsPolitics

MSF warns of US/Indian tension over generic policy discussion

MSF warns of US/Indian tension over generic policy discussion

25-09-2013

Humanitarian group Médecins Sans Frontières has warned that India is facing political pressure from…

Anti-viralsAsia-PacificBayerGenericsGleevecHealthcareNexavarNorth AmericaNovartisPolitics

Australia needs policies that increase generic medicine use

24-09-2013

Australia’s Generic Medicines Industry Association strongly refutes claims by the Consumer Health Forum…

Asia-PacificGenericsMarkets & MarketingPolitics

Generic medicines can fund Australian government reforms

31-07-2013

As Australia holds its collective breath waiting for the election date, minds turn to how the next the…

Asia-PacificGenericsHealthcarePolitics

Government health care reforms foster development China's Pharma market, says F&S

28-05-2013

Rising incomes, improving health care infrastructure and enhanced insurance systems have propelled the…

Asia-PacificGenericsHealthcareMarkets & MarketingPatentsPharmaceuticalPolitics

Australia's 2013-14 Budget includes investment in health services and PBS

14-05-2013

The Australian government today (May 14) presented its Budget for 2013-2014, saying that it delivers…

Asia-PacificFinancialGenericsPharmaceuticalPoliticsPricing

Activists protest in front of the European Parliament to stop EU-India trade deal "harmful" provisions

09-04-2013

As European Commission pressure mounts on India to rush into signing a free trade agreement (FTA) by…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPoliticsPricing

DNP+ and MSF urge India to reject EU demands on trade deal before April deadline

13-03-2013

Pressure is mounting on India to quickly sign off on a free trade agreement with the European Union which…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPolitics

Indian government endorses plan to cap prices of 348 drugs

23-11-2012

India's Union Cabinet yesterday endorsed the Group of Ministers' (GoM) recommendations on the National…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

Indian govt pressed to adopt market-based drug pricing by ASSOCHAM

22-11-2012

India's Associated Chambers of Commerce and Industry (ASSOCHAM) believes that the Supreme Court ruling…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

Japan's dilemma: Generics vs long-listed brands, by P Reed Maurer

30-10-2012

In most countries, promoting generics to save money in the health care budget is considered good policy.…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

India finalizes pharma pricing policy, which will cover 348 drugs

28-09-2012

India's Group of Ministers (GoM), headed by Agriculture Minister Sharad Pawar, yesterday finalized the…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

Indian pharma traders urge government to speed up national drug pricing policy

19-09-2012

The All India Organization of Chemists and Druggists (AIOCD) - the single largest body of the drug traders…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

PhRMA disputes Indian claims relating to cancer drug shortages

27-08-2012

In a recent interview with Times of India, a trade association that represents several major generic…

Asia-PacificGenericsNorth AmericaPatentsPharmaceuticalPolitics

Russia urged to open up its pharmaceuticals market to Indian imports

04-07-2012

Russia should open its booming $19 billion pharmaceuticals market and expedite the list of 500 drugs…

Asia-PacificEuropeGenericsMarkets & MarketingPoliticsRegulation

Further protests from activists against EU and India FTA

10-02-2012

As India and the European Union meet today for a Summit in New Delhi to iron out the differences over…

Asia-PacificEuropeGenericsMarkets & MarketingPatentsPharmaceuticalPolitics

Australia’s generics sector stresses need for sustainable PBS

14-12-2011

Ensuring the Pharmaceutical Benefits Scheme (PBS) is sustainable and medicines remain affordable and…

Asia-PacificGenericsHealthcarePoliticsPricing

GMiA welcomes TGA blueprint for reform

11-12-2011

Australia’s Generic Medicines Industry Association (GMiA) says it welcomes the release last week…

Asia-PacificGenericsPoliticsRegulation

Govt officials and regulators in India consult on stopping spurious drugs

05-10-2011

A national consultation meeting was held in India this week to build consensus on the methodology needed…

Asia-PacificGenericsPharmaceuticalPoliticsRegulation

Australia’s generics firms also welcome Senate report on government administration of the PBS

21-08-2011

Following the release of the Australia’s Senate Finance and Administration References Committee…

Asia-PacificGenericsHealthcarePharmaceuticalPoliticsRegulation

Back to top